These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 1577403)

  • 21. Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology.
    Alter J; Lou F; Rabinowitz A; Yin H; Rosenfeld J; Wilton SD; Partridge TA; Lu QL
    Nat Med; 2006 Feb; 12(2):175-7. PubMed ID: 16444267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Observation on incorporation of 3H-taurine in mouse skeletal muscle cells by light and electron microscopic radioautography.
    Terauchi A; Nagata T
    Cell Mol Biol (Noisy-le-grand); 1993 Jun; 39(4):397-404. PubMed ID: 8329980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenytoin application in murine muscular dystrophy: behavioral improvement with no change in the abnormal intracellular Na:K ratio in skeletal muscles.
    Silverman H; Atwood HL; Bloom JW
    Exp Neurol; 1978 Dec; 62(3):618-27. PubMed ID: 750214
    [No Abstract]   [Full Text] [Related]  

  • 24. Level of nerve growth factor-like immunoreactivity in the lower limb muscles of muscular dystrophic mice.
    Furukawa S; Hayashi K; Ohi T; Imura H
    Biochem Biophys Res Commun; 1979 Sep; 90(1):130-4. PubMed ID: 496965
    [No Abstract]   [Full Text] [Related]  

  • 25. Alteration of the ganglioside composition of skeletal muscle in murine muscular dystrophy.
    Max SR; Brady RO
    Nat New Biol; 1971 Sep; 233(36):55-6. PubMed ID: 5286359
    [No Abstract]   [Full Text] [Related]  

  • 26. Metabolism of selenium in skeletal muscle and liver of mice with genetic muscular dystrophy.
    Revis NW; Horton CY; Curtis S
    Proc Soc Exp Biol Med; 1979 Feb; 160(2):139-43. PubMed ID: 419136
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of protease-treated royal jelly on muscle strength in elderly nursing home residents: A randomized, double-blind, placebo-controlled, dose-response study.
    Meng G; Wang H; Pei Y; Li Y; Wu H; Song Y; Guo Q; Guo H; Fukushima S; Tatefuji T; Wang J; Du H; Su Q; Zhang W; Shen S; Wang X; Dong R; Han P; Okazaki T; Nagatomi R; Wang J; Huang G; Sun Z; Song K; Niu K
    Sci Rep; 2017 Sep; 7(1):11416. PubMed ID: 28900247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased level of immunoreactive epidermal growth factor in the hindlimb muscle of muscular dystrophic mice.
    Hiramatsu M; Kashimata M; Murayama M; Sato A; Ueda K; Maeda N; Kumegawa M; Minami N
    Shika Kiso Igakkai Zasshi; 1989 Apr; 31(2):224-6. PubMed ID: 2519267
    [No Abstract]   [Full Text] [Related]  

  • 29. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study.
    Zhao Y; Haginoya K; Sun G; Dai H; Onuma A; Iinuma K
    J Pathol; 2003 Sep; 201(1):149-59. PubMed ID: 12950028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice.
    Schertzer JD; Ryall JG; Lynch GS
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E499-505. PubMed ID: 16621899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Muscle protein turnover in the dystrophic mice].
    Mizobuchi M
    Rinsho Shinkeigaku; 1983 May; 23(5):436-44. PubMed ID: 6883888
    [No Abstract]   [Full Text] [Related]  

  • 32. Reduced level of epidermal growth factor in the skeletal muscle of mice with muscular dystrophy.
    Hiramatsu M; Kashimata M; Takayama F; Tsubakida K; Ri K; Minami N
    Horm Metab Res; 1992 Mar; 24(3):138-9. PubMed ID: 1577403
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.